Xylem Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Xylem Inc. on February 25, 2016. The report details corporate governance amendments adopted by the Board of Directors on the same date.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on legal and governance matters rather than financial performance.
Material Changes
The primary material change is the adoption of the Third Amended and Restated By-laws to implement proxy access. Key provisions include:
- Proxy Access: Shareholders (or groups of up to 20) owning at least 3% of outstanding common stock continuously for three years may nominate up to 20% of the board or two directors, whichever is greater.
- Advance Notice: Clarified provisions and defined terms regarding shareholder nominations.
- Meeting Authority: Clarified the Chairman's authority to convene and adjourn shareholder meetings.
- Indemnification: Updated provisions to clarify that indemnification and expense advancement are generally unavailable for claims brought by indemnitees and require an undertaking to repay expenses.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. No specific risks or contingencies related to financial performance are disclosed in this document.
Key Facts for Investor Verification
- Verify the specific ownership thresholds (3% for 3 years) required to utilize the new proxy access provisions.
- Confirm the nomination window (150 to 120 days prior to the anniversary of the previous proxy statement) for submitting director nominees.
- Review the full text of the Third Amended and Restated By-laws (Exhibit 3.1) for detailed procedural requirements regarding indemnification and expense advancement.